CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 31 enrolled
Drug / intervention
Metoclopramide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00355394
NCT00355394Phase 2Completed
CompareCT.gov

Treatment of Acute Migraine Headache in Children

Children's Hospital of Philadelphia·interventional·Posted Jul 21, 2006·Updated Nov 30, 2015

In Brief

A Phase 2 clinical trial evaluating Metoclopramide and Placebo for Migrainous Headache. Completed, enrolled 31 participants across 1 site.

Detailed Summary

Migraine is common in children and is one of the most common etiologies of headache leading to emergency room presentation in children. Despite this, few studies have investigated the treatment of acute migraine headache in the emergency room. We will perform a prospective, double-blind, placebo-controlled study of metoclopramide versus placebo in the treatment of acute migraine headache. The primary outcome will be the number of subjects headache free at two hours.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigrainous Headache
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 21, 2006
Enrollment StartAug 1, 2006
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 19.9 years ago

Interventions

Metoclopramidedrug

Intravenous bolus administration.

Placeboother

Standard care including intravenous fluid, but no metoclopramide.